ERBB3 and neoplasm: Aligned with the tumor growth kinetics, immunostaining (immunohistochemistry, (IHC)) showed that in PIK3CA wild type Cal27 cells, inhibition of HER3 by CDX-3379 decreased pS6, which correlated with decreased proliferation as depicted by BrdU incorporation.